...
首页> 外文期刊>Journal of Analytical Toxicology >Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application.
【24h】

Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application.

机译:芬太尼:有毒性或治疗性?透皮芬太尼应用后的死后和死前血药浓度。

获取原文
获取原文并翻译 | 示例

摘要

In forensic toxicology, several fatal intoxications with fentanyl have occurred in the recent past, but there are rare discussions in the literature of postmortem fentanyl blood concentrations subsequent to lethal and non lethal applications. To study this problem, we analyzed postmortem blood concentrations (vena femoralis) of 118 cases with therapeutic use of fentanyl and compared them with serum levels of 27 living persons after therapeutic administration of fentanyl patches (Durogesic). Basically, blood concentrations in postmortem specimens cannot be directly compared with in vivo serum levels: in our study, we observed that postmortem fentanyl blood concentrations were on average up to nine times higher than in vivo serum levels at the same dose. These differences could be explained by postmortem redistribution, but they were higher than expected on the basis of the physical and chemical properties of fentanyl alone. The special pharmacokinetics of the drug after long term transdermal application seem to play an important role in this phenomenon. In addition, there was no clear correlation between transdermal fentanyl dose and blood or serum concentrations, either antemortem or postmortem. Our study provides extensive data for postmortem peripheral blood concentrations after therapeutic non-fatal fentanyl patch application and demonstrates once more that in forensic toxicology, blood concentrations must be holistically interpreted with respect to all aspects of a case.
机译:在法医毒理学中,最近曾发生过数种致命的芬太尼中毒事件,但是在致死性和非致死性应用后,死后芬太尼的血药浓度在文献中鲜有讨论。为了研究该问题,我们分析了芬太尼治疗后118例患者的死后血液浓度(股静脉),并将其与芬太尼贴剂(Durogesic)治疗后的27名活人的血清水平进行了比较。基本上,死后标本中的血药浓度不能直接与体内血清水平进行比较:在我们的研究中,我们观察到在相同剂量下,死后芬太尼的血药浓度平均比体内血清浓度高出九倍。这些差异可以通过事后再分配来解释,但仅基于芬太尼的物理和化学性质,它们就比预期的要高。长期经皮应用后,该药物的特殊药代动力学似乎在该现象中起重要作用。此外,芬太尼透皮剂量与血液或血清浓度(死前或死后)之间没有明确的相关性。我们的研究为治疗性非致命性芬太尼贴剂应用后的死后外周血浓度提供了广泛的数据,并再次证明在法医毒理学中,必须对病例的各个方面进行全面的血液浓度解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号